Eli Lilly is one of the top growing stocks at the moment. Learn the reasons why this might be a stock to consider.

Pharmaceutical giant Eli Lilly said last week that it will raise the U.K. list price of its weight-loss treatment Mounjaro by ...

The UK list price of the weight loss drug could nearly triple, but which patients will bear the brunt of the internationally “aligned” cost? Kate Bowie reports In May the Trump administration demanded ...

The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.

Viking Therapeutics (VKTX) shares plunge after revealing a high dropout rate in the phase 2 trial for its weight-loss pill. ...

Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official ...

Eli Lilly's recent performance showcases a robust recovery, driven by impressive sales of its obesity drugs, Mounjaro and ...

One of the harsh realities of the equities arena is that it’s open and entropic. In other words, exogenous factors could come ...

New pill orforglipron was associated with a significant reduction in body weight and better cholesterol, triglycerides and blood pressure.

After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...

Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, Reuters writes ...

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...